ASLAN Pharmaceuticals

Investor Relations

About ASLAN

About ASLAN

ASLAN Pharmaceuticals is a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients.

News Releases
Date Title
Jul 13, 2020
ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
May 11, 2020
ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
Apr 13, 2020
UPDATE - ASLAN Pharmaceuticals Temporarily Pauses Recruitment of New Patients Into ASLAN004 Study Due to COVID-19
Read More
Upcoming Events
More events are coming soon.
Read More

Investor Relations
E-mail: investor@aslanpharma.com

Stock Service Agent
Agency: CAPITAL Securities Co. Ltd Registrar Department
Address: B2 No.97, Sec. 2, Dunhua S. Rd., Daan Dist., Taipei City 106, Taiwan (R.O.C.)
Telephone: +886 2 2702 3999 (registered number)
https://www.capital.com.tw